Sangamo BioSciences to offer shares, stock falls


Sangamo BioSciences (SGMO) announces a planned public offering.

The size of the deal is not disclosed.

There will be a 15% underwriter option. (PR)

Shares -5.4% AH

From other sites
Comments (1)
  • podell2
    , contributor
    Comments (7) | Send Message
     
    The way I see it, one key to success is having enough cash to get your research done and to strengthen your position negotiating with potential partners. So, I view raising cash as a positive. That said, why are their HIV studies limited to so very few patients. I'd hope they could expand the number of patients studied and advance this treatment more quickly.

     

    Richard Podell, MD
    18 Sep 2013, 12:21 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs